Pullen Investment Management LLC Invests $377,000 in Revvity Inc. (NYSE:RVTY)

Pullen Investment Management LLC purchased a new position in Revvity Inc. (NYSE:RVTY - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 3,564 shares of the company's stock, valued at approximately $377,000.

A number of other hedge funds have also recently made changes to their positions in the stock. Nissay Asset Management Corp Japan ADV raised its holdings in Revvity by 0.6% in the fourth quarter. Nissay Asset Management Corp Japan ADV now owns 15,023 shares of the company's stock worth $1,682,000 after purchasing an additional 91 shares in the last quarter. Quarry LP grew its position in shares of Revvity by 45.7% in the 4th quarter. Quarry LP now owns 303 shares of the company's stock worth $34,000 after buying an additional 95 shares during the last quarter. Signaturefd LLC raised its stake in shares of Revvity by 6.8% during the 4th quarter. Signaturefd LLC now owns 1,668 shares of the company's stock worth $186,000 after acquiring an additional 106 shares in the last quarter. RDA Financial Network lifted its position in Revvity by 3.6% during the first quarter. RDA Financial Network now owns 3,331 shares of the company's stock valued at $352,000 after acquiring an additional 115 shares during the last quarter. Finally, EverSource Wealth Advisors LLC boosted its stake in Revvity by 33.5% in the fourth quarter. EverSource Wealth Advisors LLC now owns 522 shares of the company's stock valued at $58,000 after acquiring an additional 131 shares in the last quarter. 86.65% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on RVTY shares. The Goldman Sachs Group reduced their price target on Revvity from $140.00 to $125.00 and set a "buy" rating on the stock in a research report on Tuesday, April 29th. Robert W. Baird decreased their price target on Revvity from $127.00 to $125.00 and set an "outperform" rating for the company in a research note on Tuesday, April 29th. UBS Group raised Revvity from a "neutral" rating to a "buy" rating and lowered their price target for the stock from $145.00 to $115.00 in a report on Thursday, May 1st. Barclays cut their price objective on shares of Revvity from $140.00 to $110.00 and set an "overweight" rating on the stock in a report on Thursday, April 10th. Finally, JPMorgan Chase & Co. lowered their target price on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating for the company in a research note on Tuesday, April 29th. Five investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Revvity presently has an average rating of "Moderate Buy" and a consensus target price of $125.64.

Revvity Stock Performance

Shares of RVTY stock traded down $2.13 during trading hours on Tuesday, hitting $94.22. The company's stock had a trading volume of 1,157,274 shares, compared to its average volume of 958,241. The stock has a market cap of $11.11 billion, a PE ratio of 40.09, a price-to-earnings-growth ratio of 2.35 and a beta of 0.97. Revvity Inc. has a 12-month low of $87.70 and a 12-month high of $129.50. The company has a 50 day moving average of $93.15 and a 200 day moving average of $106.51. The company has a current ratio of 3.58, a quick ratio of 2.99 and a debt-to-equity ratio of 0.41.

Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings results on Monday, April 28th. The company reported $1.01 earnings per share for the quarter, topping the consensus estimate of $0.96 by $0.05. The company had revenue of $664.76 million for the quarter, compared to the consensus estimate of $662.30 million. Revvity had a return on equity of 7.73% and a net margin of 10.35%. The firm's revenue for the quarter was up 2.3% compared to the same quarter last year. During the same period last year, the firm earned $0.98 EPS. On average, sell-side analysts forecast that Revvity Inc. will post 4.94 EPS for the current fiscal year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 8th. Stockholders of record on Friday, July 18th will be issued a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 0.30%. The ex-dividend date of this dividend is Friday, July 18th. Revvity's dividend payout ratio (DPR) is 11.91%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.